7-y results from checkmate 238: adjuvant nivo vs ipi in resected stage iii/iv melanoma
Published 10 months ago • 102 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
5:44
4-year results from checkmate 238: adjuvant nivo vs ipi in resected stage iii/iv melanoma
-
2:56
encouraging phase 3 checkmate 238 data: adjuvant nivolumab in resected stage iii/iv melanoma
-
5:30
jeffrey s weber, asco 2018 – resected stage iii melanoma and the checkmate 238 trial
-
2:22
adjuvant nivolumab in patents with high-risk resected melanoma
-
1:59
checkmate 238: nivolumab versus ipilimumab in stage iii melanoma
-
1:05
dr. weber on rationale for the checkmate-238 trial in melanoma
-
7:04
checkmate 238: adjuvant checkpoint therapy after melanoma resection
-
1:17
dr. weber on checkmate-238 compared to other trials in melanoma
-
7:39
adjuvant nivolumab versus ipilimumab for resected stage iii/iv melanoma
-
1:42
dr. weber on biomarker data from checkmate-238 for melanoma
-
3:02
checkmate 238 results presented at esmo 2017
-
1:13
case 7: echocardiography spot diagnosis case series #echocardiography #echo #cardiology
-
3:37
adjuvant therapy for resected stage iii melanoma
-
1:55
neoadjuvant ipilimumab plus nivolumab in stage iii melanoma
-
0:56
dr. weber on checkmate-238 for melanoma
-
0:59
checkmate 067: phase 3 trial of nivolumab in melanoma
-
6:07
interpreting the results of checkmate-227 in nsclc
-
2:57
neoadjuvent ipilimumab plus nivolumab beneficial compared to adjuvent nivolumab in macroscopic, ...
-
6:31
checkmate 649 biomarker analyses of nivo ipi vs chemo for patients with gc/gejc/eac